Computational Shadow-System Analysis of Drug Coverage Administration Processes to Enhance Service Efficiency

Authors

  • Dr. Thandi Dlamini School of Health Informatics and Systems Design, University of Eswatini, Kwaluseni, Eswatini

Keywords:

Computational Shadow System, Pharmacy Benefit Management, Digital Twin, Systems Pharmacology

Abstract

The increasing complexity of drug coverage administration systems in healthcare has created operational inefficiencies, delayed approvals, and suboptimal resource utilization in pharmacy benefit management (PBM) ecosystems. Traditional workflow models are often linear, rule-based, and insufficiently adaptive to dynamic patient demand, multi-stakeholder decision pathways, and evolving pharmaceutical policies. This research proposes a computational shadow-system framework integrated with multiscale pharmacological modeling and systems simulation to enhance the efficiency, responsiveness, and transparency of drug coverage administration processes.

The study synthesizes principles from quantitative systems pharmacology, multiscale biological modeling, and target-mediated drug disposition frameworks to construct a computational analog of PBM workflows. Foundational theoretical contributions from receptor-level modeling and pharmacokinetic dynamics (Lauffenburger & Linderman, 1993; Peletier & Gabrielsson, 2012) are extended to administrative process modeling, enabling structural mapping between biological regulatory systems and healthcare decision architectures. Additionally, insights from predictive mathematical scheduling models in therapeutic contexts (Orrell & Fernandez, 2010) and enzyme mechanism assay frameworks (Strelow et al., 2012) inform the design of computational decision nodes within the shadow system.

A key component of this study is the integration of digital twin concepts applied to PBM workflow simulation, enabling real-time replication of administrative processes under varying demand and policy constraints. As demonstrated in prior work on PBM workflow optimization using digital twin methodologies, simulation-driven decision modeling significantly improves operational throughput and reduces latency in authorization cycles (Nidiganti, 2023).

The proposed model introduces a layered architecture consisting of (i) patient-level demand simulation, (ii) insurer policy-rule encoding, (iii) pharmacy claim adjudication pathways, and (iv) feedback-driven optimization loops. The system enables scenario testing for policy adjustments, cost-control strategies, and service-level optimization without disrupting live operational environments.

Findings indicate that computational shadow systems can reduce administrative bottlenecks, improve decision accuracy, and enhance predictive allocation of pharmacy benefits. The study concludes that integrating systems pharmacology principles with administrative digital twins provides a novel interdisciplinary framework for healthcare operations research, with implications for scalable PBM modernization and AI-driven healthcare governance systems.

Downloads

Download data is not yet available.

References

1. D. A. Lauffenburger, and J. J. Linderman, Receptors: models for binding, trafficking, and signaling vol. 365: Oxford University Press New York:, 1993.

2. P. K. Sorger, et al., "Quantitative and systems pharmacology in the postgenomic era: new approaches to discovering drugs and understanding therapeutic mechanisms," in An NIH white paper by the QSP workshop group, 2011, pp. 1-48.

3. D. Orrell, and E. Fernandez, "Using predictive mathematical models to optimise the scheduling of anti-cancer drugs," Innovations in Pharmaceutical Technology, vol. 33, pp. 58-62, 2010.

4. J. Strelow, et al., "Mechanism of Action assays for Enzymes," edited by J. I. M. Hughes et al., Assay Guidance Manual, 2012.

5. S. Nagar, J. P. Jones, and K. Korzekwa, "A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 1. Theoretical Considerations," Drug Metab. Dispos., vol. 42, pp. 1575-1586, 2014.

6. Sravan Kumar Nidiganti. (2023). Digital Twin Technology for Simulating PBM (pharmacy Benefit Management) Workflow Improvements. Journal of Computational Analysis and Applications (JoCAAA), 31(4), 2520–2531. Retrieved from https://eudoxuspress.com/index.php/pub/article/view/4867

7. L. A. Peletier, and J. Gabrielsson, "Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification," J. Pharmacokinet. Phar., vol. 39, pp. 429-451, 2012.

8. P. J. Aston, G. Derks, B. M. Agoram, and P. H. van der Graaf, "A mathematical analysis of rebound in a target-mediated drug disposition model: I. Without feedback," J. Math. Biol., vol. 68, pp. 1453-1478, 2014.

9. P. Bonate, "What happened to the modeling and simulation revolution," Clin. Pharmacol. Ther., vol. 96, pp. 416-417, 2014.

10. P. Vicini, "Multiscale modeling in drug discovery and development: future opportunities and present challenges," Clin. Pharmacol. Ther., vol. 88, pp. 126-129, 2010.

11. T. E. Yankeelov, et al., "Clinically relevant modeling of tumor growth and treatment response," Sci. Transl. Med., vol. 5, pp. 187ps189-187ps189, 2013.

Downloads

Published

2025-11-30

How to Cite

Computational Shadow-System Analysis of Drug Coverage Administration Processes to Enhance Service Efficiency. (2025). International Bulletin of Applied Science and Technology, 5(11), 263-276. https://researchcitations.com/index.php/ibast/article/view/7339

Similar Articles

1-10 of 999

You may also start an advanced similarity search for this article.